Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ismet Culcuoglu
Observed name:
İsmet Çulcuoğlu
Institution:
Izmir Kâtip Çelebi University
Observed institution:
Izmir Kâtip Çelebi University
ORCID:
0000-0003-0333-5191
Observed ORCID:
0000-0003-0333-5191
OpenAlex ID:
A5120161580
Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group
2025
·
Salih Tunbekici
, Gokhan Sahin
, et al.
·
International Journal of Cancer
·
3
Assessment of subclinical myocardial dysfunction and osteogenic biomarkers in normoglycemic individuals with familial predisposition to type 2 diabetes mellitus
2026
·
Gökçe Eğlenoğlu
, Mert Uge
, et al.
·
Experimental and Clinical Endocrinology & Diabetes
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group
2026
·
Salih Tunbekici
, Hamit Bal
, et al.
·
Clinical & Translational Oncology
Subclinical myocardial dysfunction in normoglycemic first-degree relatives of patients with type 2 diabetes mellitus: Associations with Endothelin-1, E-selectin, and Endocan
2025
·
İsmet Çulcuoğlu
, Barış Önder Pamuk
, et al.
·
Diabetes and Vascular Disease Research
Show more works
View as search
Works count:
4
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type